[Federal Register Volume 73, Number 230 (Friday, November 28, 2008)]
[Notices]
[Page 72485]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-28335]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or Advisory
Board), National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC),
announces the following meeting of the aforementioned committee:
Board Meeting Times and Dates
9 a.m.-5 p.m., December 16, 2008.
9 a.m.-5 p.m., December 17, 2008.
9 a.m.-12:30 p.m., December 18, 2008.
Public Comment Times and Dates
5 p.m.-6 p.m., December 16, 2008.
7 p.m.-8 p.m., December 17, 2008.
Place: Augusta Marriott Hotel and Suites, Two 10th Street, Augusta,
GA 30901, Telephone (706) 724-8523, Fax (706) 823-6545.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 75 to 100 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program (EEOICP) Act of
2000 to advise the President on a variety of policy and technical
functions required to implement and effectively manage the new
compensation program. Key functions of the Advisory Board include
providing advice on the development of probability of causation
guidelines which have been promulgated by the Department of Health and
Human Services (HHS) as a final rule, advice on methods of dose
reconstruction which have also been promulgated by HHS as a final rule,
advice on the scientific validity and quality of dose estimation and
reconstruction efforts being performed for purposes of the compensation
program, and advice on petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2009.
Purpose: This Advisory Board is charged with (a) Providing advice
to the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advise the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class.
Matters To Be Discussed: The agenda for the Advisory Board meeting
includes: NIOSH Program Status Update; Special Exposure Cohort (SEC)
Petitions for: Savannah River Site (Construction Workers), Linde
Ceramics (residual period), Metallurgical Laboratory (University of
Chicago), Mallinckrodt (1958), Blockson Chemical and Vitro
Manufacturing (Canonsburg); Special Exposure Cohort (SEC) Petition
Status Update(s); Department of Labor (DOL) Update; Department of
Energy (DOE) Update; Science Issues Update; Work Group reports;
Subcommittee on Dose Reconstruction Reviews Report; and Board Future
Plans and Schedules.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may be
submitted according to the policy provided below. Any written comments
received will be provided to the Board at the meeting and should be
submitted to the contact person below well in advance of the meeting.
Policy on Redaction of Board Meeting Transcripts (Public Comment),
(1) If a person making a comment gives his or her name, no attempt will
be made to redact that name. (2) NIOSH will take reasonable steps to
ensure that individuals making public comment are aware of the fact
that their comments (including their name, if provided) will appear in
a transcript of the meeting posted on a public Web site. Such
reasonable steps include: (a) A statement read at the start of each
public comment period stating that transcripts will be posted and names
of speakers will not be redacted; (b) A printed copy of the statement
mentioned in (a) above will be displayed on the table where individuals
sign up to make public comment; (c) A statement such as outlined in (a)
above will also appear with the agenda for a Board Meeting when it is
posted on the NIOSH Web site; (d) A statement such as in (a) above will
appear in the Federal Register Notice that announces Board and
Subcommittee meetings. (3) If an individual in making a statement,
reveals personal information (e.g., medical information) about
themselves that information will not usually be redacted. The NIOSH
Freedom of Information Act (FOIA) coordinator will, however, review
such revelations in accordance with the Freedom of Information Act and
the Federal Advisory Committee Act and if deemed appropriate, will
redact such information. (4) All disclosures of information concerning
third parties will be redacted. (5) If it comes to the attention of the
Designated Federal Official (DFO) that an individual wishes to share
information with the Board but objects to doing so in a public forum,
the DFO will work with that individual, in accordance with the Federal
Advisory Committee Act, to find a way that the Board can hear such
comments.
Contact Person for More Information: Theodore Katz, M.P.A.,
Executive Secretary, NIOSH, CDC, 1600 Clifton Road, MS E-20, Atlanta GA
30333, Telephone (513) 533-6800, Toll Free 1 (800) CDC-INFO, E-mail
[email protected].
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: November 21, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-28335 Filed 11-26-08; 8:45 am]
BILLING CODE 4163-18-P